Journal of Medicinal Chemistry · 2018 · 29 citations · 37 references
MedicineMedicinal ChemistryPharmacologyMolecular PharmacologyPain ManagementPain MedicineAnalgesiaAnalgesic PharmacologyAnti-inflammatory PharmacologyInflammatory PainPain PhysiologyPharmacologic Pain TherapyAnalgesic Drug DevelopmentMechanical HyperalgesiaPain PharmacologyPharmacologic AnalgesiaPharmacologic Management Of PainPharmacologic Pain TreatmentPharmacological Pain ReliefThermal Hyperalgesia
3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, respectively, following intraperitoneal (IP) doses of 30 mg/kg. The observed efficacy could be correlated with the mouse dorsal root ganglion exposure and NaV1.7 potency associated with 29.
37
The Economic Costs of Pain in the United States
Darrell J. Gaskin, Patrick Richard · Journal of Pain · 2012 · 2.4K citations
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox, Frank Reimann, Adeline K. Nicholas et al. · Nature · 2006 · 1.6K citations · Full text